Albuterol HFA Related Published Studies
Well-designed clinical trials related to Albuterol HFA
Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma. [2009.08]
High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. [2009.08]
Safety of daily albuterol in infants with a history of bronchospasm: a multi-center placebo controlled trial. [2009.07.16]
Home use of albuterol for asthma exacerbations. [2009.06]
The effects of nebulized albuterol on esophageal function in asthmatic patients. [2008.10]
Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma. [2008.10]
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. [2008.09]
Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. [2008.08]
Temporal strength changes from resistance exercise and albuterol on unloaded muscle. [2008.07]
Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]
Albuterol and exercise effects on ankle extensor strength during 40 days of unloading. [2008.06]
Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Comparison of nebulized epinephrine to albuterol in bronchiolitis. [2008.04]
The Effects of Nebulized Albuterol on Esophageal Function in Asthmatic Patients. [2008.02.13]
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. [2008.01.08]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. [2008]
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]
Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction. [2007.09]
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. [2007.06.02]
Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. [2007.06]
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. [2007.05.17]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma. [2007]
A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. [2006.11]
Evaluation of the efficacy and safety of levalbuterol in subjects with COPD. [2006.08]
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]
Assessing the Effects of Racemic and Single-Enantiomer Albuterol on Airway Secretions in Long-term Intubated Patients. [2006.01]
Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. [2006.01]
Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma. [2005.12]
Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. [2005.11]
Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. [2005.10]
Regular vs ad-lib albuterol for patients hospitalized with acute asthma. [2005.09]
Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. [2005.09]
Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis. [2005.08]
Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. [2005.07]
A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD. [2005.07]
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]
Albuterol aids resistance exercise in reducing unloading-induced ankle extensor strength losses. [2005.05]
The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers. [2005.01]
Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. [2005]
Well-designed clinical trials possibly related to Albuterol HFA
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. [2009.08.29]
A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination. [2009.08]
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. [2009.08]
Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial. [2009.07]
Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. [2009.07]
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. [2009.06.30]
Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers. [2009.06]
Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. [2009.06]
Signs and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing. [2009.06]
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. [2009.06]
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids. [2009.05]
Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids. [2009.05]
Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. [2009.05]
Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. [2009.05]
Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. [2009.04]
High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone. [2009.04]
Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. [2009.04]
Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. [2009.04]
Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. [2009.04]
Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. [2009.04]
Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone. [2009.03]
Asthma control over 3 years in a real-life study. [2009.03]
Fluctuation analysis of lung function as a predictor of long-term response to beta2-agonists. [2009.03]
Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. [2009.02]
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study. [2009.02]
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. [2009.02]
Oral prednisolone for preschool children with acute virus-induced wheezing. [2009.01.22]
Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease. [2009.01]
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. [2009.01]
Intravenous salbutamol for external cephalic version. [2009.01]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009]
Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma : a randomized, double-blind, placebo-controlled pilot study. [2009]
Efficacy and cost comparisons of bronchodilatator administration between metered dose inhalers with disposable spacers and nebulizers for acute asthma in an inner-city adult population. [2008.12.10]
Salbutamol relative lung and systemic bioavailability of large and small spacers. [2008.12]
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. [2008.12]
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. [2008.12]
Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial. [2008.12]
A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma. [2008.12]
Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea. [2008.12]
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. [2008.11]
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. [2008.11]
A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation. [2008.11]
Effects of pre- vs. intra-dialysis folic acid on arterial wave reflections and endothelial function in patients with end-stage renal disease. [2008.11]
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. [2008.10.29]
Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD. [2008.10]
Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. [2008.10]
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down". [2008.10]
A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood. [2008.10]
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. [2008.08.15]
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. [2008.08]
Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. [2008.08]
FEV1 response to bronchodilation in an adult urban population. [2008.08]
Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets. [2008.08]
Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. [2008.08]
|
